|
FANCM expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.535600E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.795900E-02 |
| Normal-vs-Stage2 |
1.640210E-01 |
| Normal-vs-Stage3 |
1.619340E-03 |
| Normal-vs-Stage4 |
2.328000E-01 |
| Stage1-vs-Stage2 |
8.872200E-01 |
| Stage1-vs-Stage3 |
9.418200E-02 |
| Stage1-vs-Stage4 |
7.525000E-01 |
| Stage2-vs-Stage3 |
3.574400E-01 |
| Stage2-vs-Stage4 |
8.506200E-01 |
| Stage3-vs-Stage4 |
6.690800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.696100E-03 |
| Normal-vs-AfricanAmerican |
1.494770E-01 |
| Normal-vs-Asian |
7.772200E-01 |
| Caucasian-vs-AfricanAmerican |
5.958600E-01 |
| Caucasian-vs-Asian |
6.357600E-01 |
| AfricanAmerican-vs-Asian |
6.751800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.423200E-03 |
| Normal-vs-Female |
3.284300E-02 |
| Male-vs-Female |
4.146800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.507900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.685600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.638900E-04 |
| Normal-vs-Age(81-100Yrs) |
6.816300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.026200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.364400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.843400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.495800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.106300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.643200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.649400E-01 |
| Normal-vs-Grade 2 |
2.134200E-01 |
| Normal-vs-Grade 3 |
3.96690000000754E-05 |
| Normal-vs-Grade 4 |
1.510050E-01 |
| Grade 1-vs-Grade 2 |
1.794620E-01 |
| Grade 1-vs-Grade 3 |
5.822600E-03 |
| Grade 1-vs-Grade 4 |
5.220400E-02 |
| Grade 2-vs-Grade 3 |
7.577600E-04 |
| Grade 2-vs-Grade 4 |
3.326800E-01 |
| Grade 3-vs-Grade 4 |
8.534000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.873410E-01 |
| Normal-vs-ccB subtype |
3.802900E-04 |
| ccA subtype-vs-ccB subtype |
8.715200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.326230E-01 |
| Normal-vs-N1 |
1.975380E-04 |
| N0-vs-N1 |
4.438800E-03 |
|
|
